Efficacy of 0.01% atropine for myopia control in a randomized, placebo-controlled trial depends on baseline electroretinal response

Efficacy of 0.01% atropine for myopia control in a randomized, placebo-controlled trial depends on baseline electroretinal response

Abstract This study aimed to evaluate the efficacy of 18-month 0.01% atropine in 61 myopic children (aged 7–10) and the relationship with central retinal response (by multifocal electroretinogram [mfERG]) in a double-masked randomized placebo-controlled clinical trial. Global-flash mfERG was measure...

Full description

Bibliographic Details
Main Authors: Henry H. L. Chan, Kai Yip Choi, Alex L. K. Ng, Bonnie N. K. Choy, Jonathan Cheuk Hung Chan, Sonia S. H. Chan, Serena Z. C. Li, Wing Yan Yu
Format: Article
Language:English
Published: Nature Portfolio 2022-07-01
Series:Scientific Reports
Online Access:https://doi.org/10.1038/s41598-022-15686-6

Similar Items

Similar Items